Compass gains FDA Fast Track status for biliary tract cancer candidate

Published on 25 Apr 2024 on Seeking Alpha

Compass Therapeutics receives FDA Fast Track designation for CTX-009 in combination with paclitaxel...

Read the rest of the article

Start tracking your investments with Statfolio

During the earnings call, Beyond Inc. provided second-quarter guidance that matched Compass Point...

Investing.com 10 May 2024

Last week saw the newest quarterly earnings release from Compass Minerals International, Inc. (NY...

Simply Wall St. via Yahoo Finance 10 May 2024

Compass Minerals International, Inc. (NYSE:CMP) Q2 2024 Earnings Call Transcript May 8, 2024 Comp...

Insider Monkey via Yahoo Finance 9 May 2024

Compass, Inc. (COMP) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 8 May 2024

GUNN & Co INVESTMENT MANAGEMENT INC. purchased a new position in Truist Financial Co. (NYSE:TFC –...

ETF DAILY NEWS 5 May 2024

Wall Street Analysts Expect Share Prices For These Dividend Stocks To Shoot Up By Over 50% Benzin...

Benzinga via Yahoo Finance 3 May 2024

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insid...

Simply Wall St. via Yahoo Finance 28 Apr 2024

Compass Therapeutics receives FDA Fast Track designation for CTX-009 in combination with paclitax...

Seeking Alpha 25 Apr 2024

The brokerage presently has a $42.00 price target on the insurance provider’s stock, up from thei...

ETF DAILY NEWS 25 Apr 2024

(NYSE:IPG – Free Report) by 24.2% during the fourth...The institutional investor owned 75,069 sha...

ETF DAILY NEWS 20 Apr 2024